Roles for neuregulins in human cancer

Clinical and Experimental Metastasis

Volumn 21, Issue 8, 2005, Pages 665-684

  Stove, Christophe ^a,b   Bracke, Marc ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Apoptosis; Cancer; ErbB HER; Growth factor; Neuregulin

Indexed keywords

ANTIESTROGEN; AUTOCRINE MOTILITY FACTOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE RECEPTOR ANTAGONIST; DIMER; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; ETOPOSIDE; GELATINASE B; GELATINASE INHIBITOR; HORMONE; MATRIX METALLOPROTEINASE INHIBITOR; NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE; TAMOXIFEN;

AUTOCRINE EFFECT; BREAST EPITHELIUM; CANCER; CANCER GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; DRUG EFFECT; EPITHELIUM CELL; GENE LOCUS; GENE MUTATION; HUMAN; MALIGNANT TRANSFORMATION; MESENCHYME; NONHUMAN; PARACRINE SIGNALING; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; SURVIVAL;

ANIMALS; HUMANS; LIGANDS; NEOPLASMS; NEUREGULINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 19944404432     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-004-6917-6     Document Type: Review

References (231)

1. MA Olayioye RM Neve HA Lane NE. Hynes 2000 The ErbB signaling network: Receptor heterodimerization in development and cancer EMBO J. 19 3159 67
2. Y Yarden MX. Sliwkowski 2001 Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 127 37
3. erbB3 possesses an impaired tyrosine kinase activity Proc Natl Acad Sci USA 91 8132 6
4. SL Sierke K Cheng H-H Kim JG. Koland 1997 Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein Biochem J 322 757 63
5. DJ Slamon GM Clark SG Wong 1987 Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/ neu oncogene Science 235 177 82
6. J RévillionF. Bonneterre JP. Peyrat 1998 ERBB2 oncogene in human breast cancer and its clinical significance Eur J Cancer 34 791 808
7. P Blume-Jensen T. Hunter 2001 Oncogenic kinase signalling Nature 411 355 65
8. E Peles SS Bacus RA Koski 1992 Isolation of the Neu/HER-2 stimulatory ligand: A 44 kD glycoprotein that induces differentiation of mammary tumor cells Cell 69 205 16
9. D Wen E Peles R. Cupples 1992 Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit Cell 69 559 72
10. WE Holmes MX Sliwkowski RW. Akita 1992 Identification of heregulin, a specific activator of p185 erb B2 Science 256 1205 10
11. MA Marchionni ADJ Goodearl MS Chen 1993 Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system Nature 362 312 8
12. DL Falls KM Rosen G Corfas 1993 ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family Cell 72 801 15
13. DL. Falls 2003 Neuregulins: functions, forms, and signaling strategies Exp Cell Res 284 14 30
14. GD Plowman GS Whitney MG. Neubauer 1990 Molecular cloning and expression of an additional epidermal growth factor receptor-related gene Proc Natl Acad Sci USA 87 4905 9
15. erbB4, a fourth member of the epidermal growth factor receptor family Proc Natl Acad Sci USA 90 1746 50
16. erbB4 Nature 366 473 5
17. D Meyer C. Birchmeier 1994 Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development Proc Natl Acad Sci USA 91 1064 8
18. D Meyer T Yamaai A. Garratt 1997 Isoform-specific expression and function of neuregulin Development 124 3575 86
19. H Chang DJ Riese II W. Gilbert 1997 Ligands for ErbB-family receptors encoded by a neuregulin-like gene Nature 387 509 12
20. KL Carraway III JL Weber MJ. Unger 1997 Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases Nature 387 512 6
21. SJ Busfield DA Michnick TW. Chickering 1997 Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus Mol Cell Biol 17 4007 14
22. D Zhang MX Sliwkowski M. Mark 1997 Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4 Proc Natl Acad Sci USA 94 9562 67
23. D Harari E Tzahar J. Romano 1999 A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase Oncogene 18 2681 9
24. A Orr-Urtreger L Trakhtenbrot R. Ben-Levy 1993 Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21 Proc Natl Acad Sci USA 90 1867 71
25. W-H Ho MP Armanini A. Nuijens 1995 Sensory and motor neuron-derived factor A novel heregulin variant highly expressed in sensory and motor neurons. J Biol Chem 270 14523 32
26. Q Li JA. Loeb 2001 Neuregulin-heparan-sulfate proteoglycan interactions produce sustained erbB receptor activation required for the induction of acetylcholine receptors in muscle J Biol Chem 276 38068 75
27. A Schroering DJ. Carey 1998 Sensory and motor neuron-derived factor is a transmembrane heregulin that is expressed on the plasma membrane with the active domain exposed to the extracellular environment J Biol Chem 273 30643 50
28. JY Wang SJ Miller DL. Falls 2001 The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain J Biol Chem 276 2841 51
29. H Cabedo C Luna AM. Fernández 2002 Molecular determinants of the sensory and motor neuron-derived factor insertion into plasma membrane J Biol Chem 277 19905 12
30. HS Lu D Chang JS. Philo 1995 Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors Similarities and differences of the α and β isoforms J Biol Chem 270 4784 91
31. HS Lu S Hara LW-I. Wong 1995 Post-translational processing of membrane-associated neu differentiation factor proisoforms expressed in mammalian cells J Biol Chem 270 4775 83
32. D Wen SV Suggs D. Karunagaran 1994 Structural and functional aspects of the multiplicity of Neu differentiation factors Mol Cell Biol 14 1909 19
33. JY Wang KE Frenzel D Wen DL. Falls 1998 Transmembrane neuregulins interact with LIM kinase 1, a cytoplasmic protein kinase implicated in development of visuospatial cognition J Biol Chem 273 20525 34
34. K Yoshioka V Foletta O Bernard K Itoh 2003 A role for LIM kinase in cancer invasion Proc Natl Acad Sci USA 100 7247 52
35. J Bao D Wolpowitz LW Role DA. Talmage 2003 Back signaling by the Nrg-1 intracellular domain J Cell Biol 161 1133 41
36. W Li JW Park A. Nuijens 1996 Heregulin is rapidly translocated to the nucleus and its transport is correlated with c- myc induction in breast cancer cells Oncogene 1996 12 2473 7
37. RJ Gilbertson SC Clifford W. MacMeekin 1998 Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma Cancer Res 58 3932 41
38. Ø Fluge LA Akslen DRF. Haugen 2000 Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas Int J Cancer 87 763 70
39. X Liu H Hwang L. Cao 1998 Domain-specific gene disruption reveals critical regulation of neuregulin signaling by its cytoplasmic tail Proc Natl Acad Sci USA 95 13024 9
40. X Liu H Hwang L. Cao 1998 Release of the neuregulin functional polypeptide requires its cytoplasmic tail J Biol Chem 273 34335 40
41. B Han GD. Fischbach 1999 The release of acetylcholine receptor inducing activity (ARIA) from its transmembrane precursor in transfected fibroblasts J Biol Chem 274 26407 15
42. TL Burgess SL Ross Y-x. Qian 1995 Biosynthetic processing of neu differentiation factor Glycosylation trafficking, and regulated cleavage from the cell surface. J Biol Chem 270 19188 96
43. KE Frenzel DL. Falls 2001 Neuregulin-1 proteins in rat brain and transfected cells are localized to lipid rafts J Neurochem 77 1 12
44. JC Montero L Yuste E. Diaz-Rodriguez 2000 Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-alpha-converting enzyme Mol Cell Neurosci 16 631 48
45. K Shirakabe S Wakatsuki T Kurisaki A. Fujisawa-Sehara 2001 Roles of meltrin β/ADAM19 in the processing of neuregulin J Biol Chem 276 9352 8
46. Z Aguilar DJ. Slamon 2001 The transmembrane heregulin precursor is functionally active J Biol Chem 276 44099 107
47. D Meyer C. Birchmeier 1995 Multiple essential functions of neuregulin in development Nature 378 386 90
48. TPJ Garrett NM McKern M. Lou 2002 Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor-α Cell 110 763 73
49. H Ogiso R Ishitani O. Nureki 2002 Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains Cell 110 775 87
50. KM Ferguson MB Berger JM. Mendrola 2003 EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization Mol Cell 11 507 17
51. TPJ Garrett NM McKern M. Lou 2003 The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors Mol Cell 11 495 05
52. HS Cho K Mason KX. Ramyar 2003 Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab Nature 421 756 60
53. HS Cho DJ. Leahy 2002 Structure of the extracellular region of'HER3 reveals an interdomain tether Science 297 1330 3
54. AW Burgess H-S Cho C. Eigenbrot 2003 An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol Cell 12 541 52
55. A Citri KB Skaria Y. Yarden 2003 The deaf and the dumb: the biology of ErbB-2 and ErbB-3 Exp Cell Res 284 54 65
56. D Dankort N Jeyabalan N. Jones 2001 Multiple ErbB-2/Neu phosphorylation sites mediate transformation through distinct effector proteins J Biol Chem 276 38921 8
57. NJ Hellyer M-S Kim JG. Koland 2001 Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor J Biol Chem 276 42153 61
58. T Holbro G Civenni NE. Hynes 2003 The ErbB receptors and their role in cancer progression Exp Cell Res 284 99 110
59. MD Marmor KB Skaria Y. Yarden 2004 Signal transduction and oncogenesis by ErbB/HER receptors Int J Radiat Oncol Biol Phys 58 903 13
60. A Wells U. Marti 2002 Signalling shortcuts: cell-surface receptors in the nucleus? Nat Rev Mol Cell Biol 3 697 702
61. G. Carpenter 2003 Nuclear localization and possible functions of receptor tyrosine kinases Curr Opin Cell Biol 15 143 8
62. L Labriola M Salatino CJ. Proietti 2003 Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells Mol Cell Biol 23 1095 111
63. WJ. Gullick 2001 Update on HER-2 as a target for cancer therapy Alternative strategies for targeting the epidermal growth factor system in cancer. Breast Cancer Res 3 390 4
64. PD Vermeer LA Einwalter TO. Moninger 2003 Segregation of receptor and ligand regulates activation of epithelial growth factor receptor Nature 422 322 6
65. Y Yang E Spitzer D. Meyer 1995 Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland J Cell Biol 131 215 26
66. FE Jones DJ Jerry BC. Guarino 1996 Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli Cell Growth Differ 7 1031 8
67. C Niemann V Brinkmann E. Spitzer 1998 Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis J Cell Biol 143 533 45
68. RK Vadlamudi R-A Wang AH. Talukder 2000 Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells Mol Cell Biol 20 9092 101
69. L Li S Cleary MA. Mandarano 2002 The breast proto-oncogene, HRGα regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland Oncogene 21 4900 7
70. FE Jones DF. Stern 1999 Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation Oncogene 18 3481 90
71. FE Jones T Welte X-Y Fu DF. Stern 1999 ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation J Cell Biol 147 77 87
72. D Graus-Porta RR Beerli NE. Hynes 1995 Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling Mol Cell Biol 15 1182 91
73. BM Marte M Jeschke D. Graus-Porta 1995 Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells Mol Endocrinol 9 14 23
74. BM Marte D Graus-Porta M Jeschke 1995 NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells Oncogene 10 167 75
75. GD Lewis JA Lofgren AE. McMurtrey 1996 Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness Cancer Res 56 1457 65
76. Z Aguilar RW Akita RS. Finn 1999 Biologic effects of heregulin/ neu differentiation factor on normal and malignant human breast and ovarian epithelial cells Oncogene 18 6050 62
77. HER2 antibody and heregulin Cancer Res 60 3522 31
78. AW Grasso D Wen CM. Miller 1997 ErbB kinases and NDF signaling in human prostate cancer cells Oncogene 15 2705 16
79. SS Bacus AV Gudkov CR. Zelnick 1993 Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: Implications for mammary tumors Cancer Res 53 5251 61
80. c-erbB2:Increased invasiveness may contribute to poor prognosis Clin Cancer Res 3 1629 34
81. M Offterdinger SM Schneider TW. Grunt 2003 Heregulin and retinoids synergistically induce branching morphogenesis of breast cancer cells cultivated in 3D collagen gels J Cell Physiol 195 260 75
82. JA Fontana AB Mezu BN Cooper D. Miranda 1990 Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells Cancer Res 50 1997 2002
83. SH Flicker SM Schneider M. Offterdinger 1997 Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-α in SK-BR-3 breast cancer cells Cancer Lett 115 63 72
84. M Tan R Grijalva D. Yu 1999 Heregulin ß1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase Cancer Res 59 1620 5
85. A Chausovsky I Tsarfaty Z. Kam 1998 Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells Mol Biol Cell 9 3195 209
86. JM Daly CB Jannot RR. Beerli 1997 Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells Cancer Res 57 3804 11
87. T Lessor J-Y Yoo M Davis AW. Hamburger 1998 Regulation of heregulinß1-induced differentiation in a human breast carcinoma cell line by the extracellular-regulated kinase (ERK) pathway J Cell Biochem 70 587 95
88. EJ Weinstein S Grimm P. Leder 1998 The oncogene heregulin induces apoptosis in breast epithelial cells and tumors Oncogene 17 2107 13
89. JM Daly MA Olayioye AM-L. Wong 1999 NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: Role of PI3 kinase and p38 MAP kinase pathways Oncogene 18 3440 51
90. X-F Le M Marcelli A. McWatters 2001 Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C α activity Oncogene 20 8258 69
91. S Grimm P. Leder 1997 An apoptosis-inducing isoform of neu differentiation factor (NDF) identified using a novel screen for dominant, apoptosis-inducing genes J Exp Med 185 1137 42
92. S Grimm EJ Weinstein IM Krane P. Leder 1998 Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in'vitro and in vivo J Exp Med 188 1535 9
93. EJ Weinstein P. Leder 2000 The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis Cancer Res 60 3856 61
94. LN Harris L Yang C. Tang 1998 Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin ß-2 Clin Cancer Res 4 1005 12
95. SJ Houston TA Plunkett DM. Barnes 1999 Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer Br J Cancer 79 1220 6
96. RI Nicholson JMW. Gee 2000 Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer Br J Cancer 82 501 13
97. R Schiff SA Massarweh J. Shou 2004 Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance. Clin Cancer Res 2004; 10: 331S-6S.
98. RI Nicholson IR Hutcheson JM. Knowlden 2004 Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clin Cancer Res 2004; 10: 346S-54S.
99. EH Raj A Skinner U. Mahji 2001 Neuregulin 1-alpha expression in locally advanced breast cancer Breast 10 41 5
100. N Normanno N Kim D. Wen 1995 Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas Breast Cancer Res Treat 35 293 7
101. A deFazio YE Chiew RL. Sini 2000 Expression of c- erb B receptors, heregulin and oestrogen receptor in human breast cell lines Int J Cancer 87 487 98
102. DW Visscher FH Sarkar TC Kasunic KB. Reddy 1997 Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia Breast Cancer Res Treat 45 75 80
103. G Pérez-Tenorio O. Stäl 2002 members of the Southeast Sweden Breast Cancer Group Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients. Br J Cancer 86 540 5
104. AD Thor S Liu S. Edgerton 2000 Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/ neu): a study of incidence and correlation with outcome in breast cancer J Clin Oncol 18 3230 9
105. TG Ram KE Kokeny CA. Dilts 1995 Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells J Cell Physiol 163 589 96
106. RM Neve T Holbro NE. Hynes 2002 Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells Oncogene 21 4567 76
107. U Vijapurkar M-S Kim JG. Koland 2003 Roles of mitogen-activated protein kinase and phosphoinositide 3′-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling Exp Cell Res 284 291 302
108. RJ Fiddes PW Janes SP. Sivertsen 1998 Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells Oncogene 16 2803 13
109. CK Tang C Perez T. Grunt 1996 Involvement of heregulin-ß2 in the acquisition of the hormone-independent phenotype of breast cancer cells Cancer Res 56 3350 8
110. M-S Tsai AE Hornby J Lakins R. Lupu 2000 Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies Cancer Res 60 5603 7
111. A Mazumdar L Adam D Boyd R. Kumar 2001 Heregulin regulation of urokinase plasminogen activator and its receptor: Human breast epithelial cell invasion Cancer Res 61 400 5
112. J Yao S Xiong K. Klos 2001 Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-ß in human breast cancer cells Oncogene 20 8066 74
113. S Meiners V Brinkmann H Naundorf W. Birchmeier 1998 Role of morphogenetic factors in metastasis of mammary carcinoma cells Oncogene 16 9 20
114. E Atlas M Cardillo I. Mehmi 2003 Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo Mol Cancer Res 1 165 75
115. M-S Tsai LA Shamon-Taylor I. Mehmi 2003 Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer Oncogene 22 761 8
116. TW Grunt M Saceda MB. Martin 1995 Bidirectional interactions between the estrogen receptor and the c erb B-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells Int J Cancer 63 560 7
117. RJ Pietras J Arboleda DM. Reese 1995 HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells Oncogene 10 2435 46
118. RB Lichtner K Parczyk W Birchmeier MR. Schneider 1999 Differential cross-talk of estrogen and growth factor receptors in two human mammary tumor cell lines J Steroid Biochem Mol Biol 71 181 9
119. MM Hijazi EW Thompson C. Tang 2000 Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines Int J Oncol 17 629 41
120. R Clarke N Brunner D. Katz 1989 The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo Mol Endocrinol 3 372 80
121. M Saceda TW Grunt R. Colomer 1996 Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines Endocrinology 137 4322 30
122. GE Stoica TF Franke A. Wellstein 2003 Heregulin-ß1 regulates the estrogen receptor-α gene expression and activity via the ErbB2/PI 3-K/Akt pathway Oncogene 22 2073 87
123. A Mazumdar R-A Wang SK. Mishra 2001 Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor Nat Cell Biol 3 30 7
124. GL Nicolson A Nawa Y. Toh 2003 Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: Role in epithelial cancer cell invasion, proliferation and nuclear regulation Clin Exp Metastasis 20 19 24
125. R Kumar R-A Wang A. Mazumdar 2002 A naturally occurring MTA1 variant sequesters oestrogen receptor- α in the cytoplasm Nature 418 654 7
126. AS Oh LA Lorant JN. Holloway 2001 Hyperactivation of MAPK induces loss of ERα expression in breast cancer cells Mol Endocrinol 15 1344 59
127. Y-L Chung M-L Sheu S-C. Yang 2002 Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer Int J Cancer 97 306 12
128. S Kato H Endoh Y. Masuhiro 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 1491 4
129. H Kurokawa AEG Lenferink JF. Simpson 2000 Inhibition of HER2/ neu (erb B-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells Cancer Res 60 5887 94
130. IM Krane P. Leder 1996 NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice Oncogene 12 1781 8
131. B Mograbi N Rochet V. Imbert 1997 Human monocytes express amphiregulin and heregulin growth factors upon activation Eur Cytokine Netw 8 73 81
132. R Vadlamudi M Mandal L. Adam 1999 Regulation of cyclooxygenase-2 pathway by HER2 receptor Oncogene 18 305 14
133. S Venkateswarlu DM Dawson P. St Clair 2002 Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells Oncogene 21 78 86
134. L Adam A Mazumdar T. Sharma 2001 A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2 Cancer Res 61 81 7
135. LMR Gilmour KG Macleod A. McCaig 2002 Neuregulin expression, function, and signaling in human ovarian cancer cells Clin Cancer Res 8 3933 42
136. R Srinivasan E Benton F. McCormick 1999 Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 α, neuregulin-1 ß, and betacellulin, in normal endometrium and endometrial cancer Clin Cancer Res 5 2877 83
137. H Kataoka T Joh K. Kasugai 1998 Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa Life Sci 63 553 64
138. H Noguchi C Sakamoto K. Wada 1999 Expression of heregulin α, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells Gastroenterology 117 1119 27
139. M Westphal L Meima E. Szonyi 1997 Heregulins and the ErbB-2/3/4 receptors in gliomas J Neurooncol 35 335 46
140. PA Ritch SL Carroll H Sontheimer 2003 Neuregulin-1 enhances motility and migration of human astrocytic glioma cells J Biol Chem 278 20971 8
141. P O-Charoenrat P Rhys-Evans S. Eccles 2000 Expression and regulation of c- ERBB ligands in human head and neck squamous carcinoma cells Int J Cancer 88 759 65
142. P O-charoenrat P Rhys-Evans WJ. Court 1999 Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c- erb B ligands Clin Exp Metastasis 17 631 9
143. A-E Al Moustafa M Alaoui-Jamali J Paterson M. O'Connor-McCourt 1999 Expression of P185erbB-2, P160erbB-3, P180erbB-4, and heregulin α in human normal bronchial epithelial and lung cancer cell lines Anticancer Res 19 481 6
144. AM Fernandes AW Hamburger BI. Gerwin 1999 Production of epidermal growth factor related ligands in tumorigenic and benign human lung epithelial cells Cancer Lett 142 55 63
145. NV Patel MJ Acarregui JM. Snyder 2000 Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro Am J Respir Cell Mol Biol 22 432 40
146. J Liu JA. Kern 2002 Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation Am J Respir Cell Mol Biol 27 306 13
147. G Sithanandam GT Smith A. Masuda 2003 Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway Carcinogenesis 24 1581 92
148. CEL Dammann HC Nielsen KL. Carraway III 2003 Role of neuregulin-1 β in the developing lung Am J Respir Crit Care Med 167 1711 6
149. M Gollamudi D Nethery J Liu JA. Kern 2004 Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines Lung Cancer 43 135 43
150. K-L Schaefer DH Wai C. Poremba 2002 Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays Virchows Arch 440 476 84
151. C Stove V Stove L. Derycke 2003 The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation J Invest Dermatol 121 802 12
152. RJ Gilbertson RH Perry PJ. Kelly 1997 Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma Cancer Res 57 3272 80
153. KB Fallon N Havlioglu LH. Hamilton 2004 Constitutive activation of the neuregulin/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line J Neurooncol 66 273 84
154. M Campiglio S Ali PG Knyazev A. Ullrich 1999 Characteristics of EGFR family-mediated HRG signals in human ovarian cancer J Cell Biochem 73 522 32
155. VRJ Schelfhout ED Coene B. Delaey 2000 Pathogenesis of Paget's disease: Epidermal heregulin- α, motility factor, and the HER receptor family J Natl Cancer Inst 92 622 8
156. JC Lyne MF Melhem GG. Finley 1997 Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro Cancer J Sci Am 3 21 30
157. HY Leung J Weston WJ Gullick G.A. Williams 1997 potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma Br J Urol 79 212 6
158. DM Danilenko BD Ring JZ. Lu 1995 Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds J Clin Invest 95 842 51
159. IY De Potter Y Poumay KA Squillace MR. Pittelkow 2001 Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation Exp Cell Res 271 315 28
160. M Piepkorn H Predd R Underwood P. Cook 2003 Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes Arch Dermatol Res 295 93 101
161. M Marikovsky S Lavi R. Pinkas-Kramarski 1995 ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes Oncogene 10 1403 11
162. MM Marqués N Martínez I Rodríguez-García A. Alonso 1999 EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT Exp Cell Res 252 432 8
163. VRJ Schelfhout ED Coene B. Delaey 2002 The role of heregulin- α as a motility factor and amphiregulin as a growth factor in wound healing J Pathol 198 523 33
164. P Castagnino MV Lorenzi J. Yeh 2000 Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors Oncogene 19 640 8
165. V De Corte C De Potter D. Vandenberghe 1994 A 50-kDa protein present in conditioned medium of COLO-16 cells stimulates cell spreading and motility, and activates tyrosine phosphorylation of Neu/HER-2, in human SK-BR-3 mammary cancer cells J Cell Sci 107 405 16
166. WI De Boer AB Houtsmuller V. Izadifar 1997 Expression and functions of EGF, FGF and TGFß-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells Int J Cancer 71 284 91
167. EMJ Bindels TH van der Kwast V. Izadifar 2002 Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2 Urol Res 30 240 7
168. MR Hansen FH. Linthicum 2004 Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: Possible autocrine loop stimulation Otol Neurotol 25 155 9
169. S Curran GI. Murray 2000 Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis Eur J Cancer 36 1621 30
170. BP Himelstein R Canete-Soler EJ Bernhard RJ. Muschel 1994 Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells J Cell Sci 107 477 86
171. SY Rha JH Kim JK. Roh 1997 Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression Breast Cancer Res Treat 43 175 81
172. AP Mazar J Henkin RH. Goldfarb 1999 The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis Angiogenesis 3 15 32
173. SB Kondapaka R Fridman KB. Reddy 1997 Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells Int J Cancer 70 722 6
174. L Puricelli CJ Proiettii L. Labriola 2002 Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells Int J Cancer 100 642 53
175. P Carmeliet RK. Jain 2000 Angiogenesis in cancer and other diseases Nature 407 249 57
176. KS Russell DF Stern PJ Polverini JR. Bender 1999 Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis Am J Physiol 277 H2205 11
177. R Bagheri-Yarmand RK Vadlamudi R-A. Wang 2000 Vascular endothelial growth factor up-regulation via p21-activated kinase-1 signaling regulates heregulin- β-mediated angiogenesis J Biol Chem 275 39451 7
178. L Yen X-L You A-E. Al Moustafa 2000 Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene 19 3460 9
179. S Xiong R Grijalva L. Zhang 2001 Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin- β-activated p38 signaling pathway enhances endothelial cell migration Cancer Res 61 1727 32
180. E Laughner P Taghavi K. Chiles 2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 α (HIF-1 α) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol Cell Biol 21 3995 4004
181. L Yen N Benlimame Z-R. Nie 2002 Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers Mol Biol Cell 13 4029 44
182. P-W Tsai S-G Shiah M-T. Lin 2003 Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin- β, A critical role of p38/nuclear factor-κB signaling pathway J Biol Chem 278 5750 9
183. P O-charoenrat P Rhys-Evans H Modjtahedi SA. Eccles 2000 Vascular endothelial growth factor family members are differentially regulated by c- erb B signaling in head and neck squamous carcinoma cells Clin Exp Metastasis 18 155 61
184. T Niki S Iba M. Tokunou 2000 Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma Clin Cancer Res 6 2431 9
185. I Alroy L Soussan R Seger Y. Yarden 1999 Neu differentiation factor stimulates phosphorylation and activation of the Sp1 transcription factor Mol Cell Biol 19 1961 72
186. M-S Tsai DF Bogart JM. Castañeda 2002 Cyr61 promotes breast tumorigenesis and cancer progression Oncogene 21 8178 85
187. AH Talukder L Adam A Raz R. Kumar 2000 Heregulin regulation of autocrine motility factor expression in human tumor cells Cancer Res 60 474 80
188. AH Talukder R Bagheri-Yarmand RRE. Williams 2002 Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors Clin Cancer Res 8 3285 9
189. M Mandal R Vadlamudi D. Nguyen 2001 Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function J Biol Chem 276 9699 704
190. AH Talukder R Vadlamudi M Mandal R. Kumar 2000 Heregulin induces expression, DNA binding activity, and transactivating functions of basic leucine zipper activating transcription factor 4 Cancer Res 60 276 81
191. AH Talukder R-A Wang R. Kumar 2002 Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells Oncogene 21 4289 300
192. AH Talukder HF Jørgensen M. Mandal 2001 Regulation of elongation factor-1 α expression by growth factors and anti-receptor blocking antibodies J Biol Chem 276 5636 42
193. M Mandal F Li R. Kumar 2002 Heregulin up-regulates heat shock protein-70 expression in breast cancer cells Anticancer Res 22 1965 9
194. F Li M Mandal CJ. Barnes 2001 Growth factor regulation of the molecular chaperone calnexin Biochem Biophys Res Commun 289 725 32
195. T Miralem HK. Avraham 2003 Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus Mol Cell Biol 23 579 93
196. CJ Barnes F Li M. Mandal 2002 Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors Cancer Res 62 1251 5
197. A. Hall 1998 Rho GTPases and the actin cytoskeleton Science 279 509 14
198. L Adam R Vadlamudi SB. Kondapaka 1998 Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase J Biol Chem 273 28238 46
199. MA Adelsman JB McCarthy Y. Shimizu 1999 Stimulation of β -integrin function by epidermal growth factor and heregulin-ß has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase Mol Biol Cell 10 2861 78
200. R Vadlamudi L Adam A. Talukder 1999 Serine phosphorylation of paxillin by heregulin- β: Role of p38 mitogen activated protein kinase Oncogene 18 7253 64
201. L Adam RK Vadlamudi P McCrea R. Kumar 2001 Tiam1 overexpression potentiates heregulin-induced lymphoid enhancer factor-1/β-catenin nuclear signaling in breast cancer cells by modulating the intercellular stability J Biol Chem 276 28443 50
202. DD Schlaepfer SK. Mitra 2004 Multiple connections link FAK to cell motility and invasion Curr Opin Genet Dev 14 92 101
203. RK Vadlamudi L Adam D. Nguyen 2002 Differential regulation of components of the focal adhesion complex by heregulin: Role of phosphatase SHP-2 J Cell Physiol 190 189 99
204. S Zrihan-Licht Y Fu J. Settleman 2000 RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion Oncogene 19 1318 28
205. GD McShan R Zagozdzon S-Y. Park 2002 Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration Int J Oncol 21 197 205
206. C Bougeret S Jiang I Keydar H. Avraham 2001 Functional analysis of Csk and CHK kinases in breast cancer cells J Biol Chem 276 33711 20
207. ME Balañá R Lupu L. Labriola 1999 Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas Oncogene 18 6370 9
208. G Mincione C Bianco S. Kannan 1996 Enhanced expression of heregulin in c-erb B-2 and c-Ha-ras transformed mouse and human mammary epithelial cells J Cell Biochem 60 437 46
209. MA Avila JA Velasco C. Cho 1995 Hyperactive autocrine loop mediated by a NDF-related factor in neoplastic hamster embryo fibroblasts expressing an activated cph oncogene Oncogene 10 963 71
210. P O-charoenrat P Rhys-Evans S. Eccles 2002 A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops Int J Cancer 100 527 33
211. K Kurohara K Komatsu T. Kurisaki 2004 Essential roles of Meltrin beta (ADAM19) in heart development Dev Biol 267 14 28
212. J Adela H-E Huang A. Murati 2003 A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/ NRG1 gene Genes Chromosom Cancer 37 333 45
213. X-Z Wang EM Jolicoeur N. Conte 1999 γ -Heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line Oncogene 18 5718 21
214. X Liu E Baker HJ. Eyre 1999 γ-Heregulin: A fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation Oncogene 18 7110 14
215. G Schaefer VD Fitzpatrick MX. Sliwkowski 1997 γ -Heregulin: A novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175 Oncogene 15 1385 94
216. EA Sánchez-Valdivieso JJ Cruz R. Salazar 2002 γ-Heregulin has no biological significance in primary breast cancer Br J Cancer 86 1362 3
217. SP Ethier KE Kokeny JW Ridings CA. Dilts 1996 ErbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line Cancer Res 56 899 907
218. E Charafe-Jauffret J-F Moulin C. Ginestier 2002 Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells Int J Oncol 21 989 96
219. HE Huang SF Chin C. Ginestier 2004 A recurrent chromosome breakpoint in breast cancer at the NRG1 / Neuregulin 1 /Heregulin gene Cancer Res 64 6840 4
220. MM Hijazi PE Young MK. Dougherty 1998 NRG-3 in human breast cancers: Activation of multiple erbB family proteins Int J Oncol 13 1061 7
221. N Nakano S Higashiyama K. Kajihara 2000 NTAK α and β isoforms stimulate breast tumor cell growth by means of different receptor combinations J Biochem 127 925 30
222. R Pinkas-Kramarski M Shelly BC. Guarino 1998 ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network Mol Cell Biol 18 6090 101
223. CS Crovello C Lai LC Cantley KL. Carraway III 1998 Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2 J Biol Chem 273 26954 61
224. C Sweeney D Fambrough C. Huard 2001 Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors J Biol Chem 276 22685 98
225. M Dunn P Sinha R. Campbell 2004 Co-expression of neuregulins 1: 2, 3 and 4 in human breast cancer J Pathol 203 672 80
226. N Nakano S Higashiyama H. Ohmoto 2004 The N-terminal region of NTAK/neuregulin-2 isoforms has an inhibitory activity of angiogenesis J Biol Chem 279 11465 70
227. D Agus R Akita W. Fox 2002 Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth Cancer Cell 2 127 37
228. M Franklin K Carey F. Vajdos 2004 Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex Cancer Cell 5 317 28
229. N Normanno C Bianco A. De Luca 2003 Target-based agents against ErbB receptors and their ligands: A novel approach to cancer treatment Endocr Relat Cancer 10 1 21
230. C. Arteaga 2003 ErbB-targeted therapeutic approaches in human cancer Exp Cell Res 284 122 30
231. D. Fry 2003 Mechanism of action of erbB tyrosine kinase inhibitors Exp Cell Res 284 131 9